See more : Suzhou Etron Technologies Co.,Ltd. (603380.SS) Income Statement Analysis – Financial Results
Complete financial analysis of ALK-Abelló A/S (AKABY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ALK-Abelló A/S, a leading company in the Biotechnology industry within the Healthcare sector.
- Devon Energy Corporation (DVN) Income Statement Analysis – Financial Results
- Smart City Development Holdings Limited (8268.HK) Income Statement Analysis – Financial Results
- Annaly Capital Management, Inc. (NLY) Income Statement Analysis – Financial Results
- ECI Technology Holdings Limited (8013.HK) Income Statement Analysis – Financial Results
- Data Storage Corporation (DTST) Income Statement Analysis – Financial Results
ALK-Abelló A/S (AKABY)
About ALK-Abelló A/S
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar. It also provides adrenaline auto-injectors for the treatment of severe allergic reactions; and manufactures products used in the diagnosis of allergies. The company offers GRAZAX, RAGWITEK, RAGWIZAX, MITICURE, ODACTRA, CEDARCURE, and ITULAZAX for the treatment of allergic rhinitis; and ACARIZAX for treating allergic rhinitis and allergic asthma. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.92B | 3.49B | 3.27B | 2.92B | 2.91B | 3.01B | 2.57B | 2.43B | 2.24B | 2.35B | 2.35B | 2.14B | 1.94B | 1.78B | 1.65B | 1.49B | 1.22B | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 1.52B | 1.46B | 1.38B | 1.28B | 1.27B | 994.00M | 836.00M | 736.00M | 697.00M | 648.00M | 611.00M | 653.00M | 587.00M | 527.00M | 499.00M | 497.00M | 413.00M | 0.00 | 0.00 | 0.00 |
| Gross Profit | 2.40B | 2.03B | 1.89B | 1.63B | 1.64B | 2.01B | 1.73B | 1.70B | 1.55B | 1.70B | 1.74B | 1.49B | 1.35B | 1.26B | 1.15B | 992.00M | 804.00M | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 61.18% | 58.09% | 57.79% | 56.02% | 56.43% | 66.92% | 67.46% | 69.75% | 68.94% | 72.37% | 73.98% | 69.49% | 69.66% | 70.46% | 69.79% | 66.62% | 66.06% | 0.00% | 0.00% | 0.00% |
| Research & Development | 631.00M | 515.00M | 466.00M | 392.00M | 426.00M | 385.00M | 407.00M | 394.00M | 463.00M | 511.00M | 455.00M | 366.00M | 349.00M | 327.00M | 323.00M | 282.00M | 232.00M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 240.00M | 237.00M | 246.00M | 227.00M | 231.00M | 198.00M | 190.00M | 199.00M | 192.00M | 203.00M | 204.00M | 208.00M | 188.00M | 178.00M | 179.00M | 176.00M | 167.00M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 1.23B | 1.13B | 1.21B | 1.14B | 1.07B | 893.00M | 843.00M | 795.00M | 762.00M | 801.00M | 781.00M | 743.00M | 672.00M | 658.00M | 640.00M | 482.00M | 358.00M | 0.00 | 0.00 | 0.00 |
| SG&A | 1.47B | 1.36B | 1.46B | 1.36B | 1.30B | 1.09B | 1.03B | 994.00M | 954.00M | 1.00B | 985.00M | 951.00M | 860.00M | 836.00M | 819.00M | 658.00M | 525.00M | 0.00 | 0.00 | 0.00 |
| Other Expenses | -1.00M | 0.00 | 0.00 | -27.00M | -2.00M | -7.00M | 0.00 | -4.00M | -1.00M | 0.00 | -2.00M | -22.00M | -37.00M | -25.00M | -207.00M | -1.00M | 45.00M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 2.10B | 1.88B | 1.92B | 1.73B | 1.72B | 1.47B | 1.44B | 1.38B | 1.42B | 1.52B | 1.44B | 1.30B | 1.17B | 1.14B | 935.00M | 939.00M | 802.00M | 0.00 | 0.00 | 0.00 |
| Cost & Expenses | 3.62B | 3.34B | 3.30B | 3.01B | 2.99B | 2.46B | 2.28B | 2.12B | 2.11B | 2.16B | 2.05B | 1.95B | 1.76B | 1.67B | 1.43B | 1.44B | 1.22B | 0.00 | 0.00 | 0.00 |
| Interest Income | 1.00M | 5.00M | 17.00M | 12.00M | 17.00M | 13.00M | 3.00M | 2.00M | 0.00 | 9.00M | 30.00M | 21.00M | 17.00M | 40.00M | 43.00M | 42.00M | 14.00M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 23.00M | 34.00M | 34.00M | 25.00M | 16.00M | 14.00M | 14.00M | 11.00M | 11.00M | 11.00M | 8.00M | 6.00M | 2.00M | 2.00M | 4.00M | 2.00M | 80.00M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 242.00M | 245.00M | 255.00M | 232.00M | 333.00M | 163.00M | 159.00M | 140.00M | 127.00M | 124.00M | 107.00M | 95.00M | 85.00M | 86.00M | 80.00M | 73.00M | 57.00M | 0.00 | 0.00 | 0.00 |
| EBITDA | 544.00M | 380.00M | 258.00M | 154.00M | 227.00M | 664.00M | 573.00M | 451.00M | 242.00M | 403.00M | 436.00M | 308.00M | 277.00M | 245.00M | 353.00M | 148.00M | 4.44B | 0.00 | 0.00 | 0.00 |
| EBITDA Ratio | 13.89% | 10.89% | 7.88% | 5.28% | 7.80% | 22.10% | 22.30% | 18.54% | 10.78% | 17.19% | 18.57% | 14.39% | 14.32% | 13.73% | 21.37% | 9.94% | 364.91% | 0.00% | 0.00% | 0.00% |
| Operating Income | 302.00M | 150.00M | -14.00M | -96.00M | -80.00M | 479.00M | 292.00M | 264.00M | 109.00M | 118.00M | 299.00M | 192.00M | 175.00M | 119.00M | 218.00M | 53.00M | 2.00M | 0.00 | 0.00 | 0.00 |
| Operating Income Ratio | 7.71% | 4.30% | -0.43% | -3.29% | -2.75% | 15.94% | 11.37% | 10.85% | 4.86% | 5.03% | 12.73% | 8.97% | 9.04% | 6.67% | 13.20% | 3.56% | 0.16% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -23.00M | -49.00M | -17.00M | -7.00M | -42.00M | 8.00M | 108.00M | 36.00M | -5.00M | -5.00M | 22.00M | 15.00M | 15.00M | 38.00M | 14.00M | 40.00M | -68.00M | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 279.00M | 101.00M | -31.00M | -103.00M | -122.00M | 487.00M | 400.00M | 300.00M | 104.00M | 113.00M | 321.00M | 207.00M | 190.00M | 157.00M | 232.00M | 93.00M | -66.00M | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 7.12% | 2.89% | -0.95% | -3.53% | -4.19% | 16.21% | 15.57% | 12.33% | 4.63% | 4.82% | 13.67% | 9.67% | 9.82% | 8.80% | 14.04% | 6.25% | -5.42% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 60.00M | 76.00M | 19.00M | 67.00M | 36.00M | 217.00M | 56.00M | 119.00M | 43.00M | 59.00M | 121.00M | 79.00M | 72.00M | 62.00M | 92.00M | 49.00M | 2.00M | 0.00 | 0.00 | 0.00 |
| Net Income | 219.00M | 25.00M | -50.00M | -170.00M | -158.00M | 270.00M | 344.00M | 181.00M | 61.00M | 209.00M | 200.00M | 128.00M | 118.00M | 95.00M | 177.00M | 24.00M | 4.30B | 0.00 | 0.00 | 0.00 |
| Net Income Ratio | 5.59% | 0.72% | -1.53% | -5.83% | -5.43% | 8.99% | 13.39% | 7.44% | 2.72% | 8.91% | 8.52% | 5.98% | 6.10% | 5.33% | 10.71% | 1.61% | 353.49% | 0.00% | 0.00% | 0.00% |
| EPS | 0.20 | 0.02 | -0.05 | -0.16 | -0.16 | 0.28 | 0.35 | 0.19 | 0.06 | 0.21 | 0.20 | 0.13 | 0.12 | 0.10 | 0.18 | 0.02 | 4.28 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.20 | 0.02 | -0.05 | -0.16 | -0.16 | 0.27 | 0.35 | 0.18 | 0.06 | 0.21 | 0.20 | 0.13 | 0.12 | 0.10 | 0.18 | 0.02 | 4.28 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 1.10B | 1.10B | 1.09B | 1.09B | 992.13M | 981.64M | 970.44M | 966.00M | 966.01M | 974.53M | 989.72M | 991.11M | 995.94M | 999.38M | 1.00B | 1.01B | 1.01B | 50.64M | 50.64M | 50.64M |
| Weighted Avg Shares Out (Dil) | 1.10B | 1.10B | 1.09B | 1.09B | 996.28M | 991.34M | 984.39M | 987.81M | 977.45M | 978.80M | 989.76M | 991.11M | 995.96M | 999.45M | 1.01B | 1.01B | 1.01B | 50.64M | 50.64M | 50.64M |
Source: https://incomestatements.info
Category: Stock Reports